Intervention

timolol maleate 0.5%

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

4 shown

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension SubjectsNCT00735449 · 2008-07-01

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension PatientsNCT00330577 · 2006-04-01

Cosopt Versus XalacomNCT00273481 · 2005-09-01

Cosopt Versus XalatanNCT00273429 · 2005-04-01

Common conditions

Ocular Hypertension4 Open-Angle Glaucoma2 Glaucoma1 Primary Open Angle Glaucoma1

Leading sponsors

Pharmaceutical Research Network2 Allergan1 Aristotle University Of Thessaloniki1

Trial status mix

COMPLETED4

Phase mix

PHASE44

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.